CSPC Ouyi Pharmaceutical Co., Ltd.
71
15
19
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
2.8%
2 terminated/withdrawn out of 71 trials
80.0%
-6.6% vs industry average
24%
17 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (71)
Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.
Role: lead
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
Role: lead
A Study of SYH2082 Injection in Healthy Participants
Role: lead
A Study of SYH2069 Injection in Healthy Participants
Role: lead
Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
Role: lead
A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid
Role: lead
Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)
Role: collaborator
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
Role: collaborator
Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Role: collaborator
A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD
Role: lead
A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes
Role: lead
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Role: collaborator
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Role: collaborator
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
Role: collaborator
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Role: collaborator
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
Role: lead
GVM±R in Patients With Relapsed or Refractory Aggressive NHL
Role: collaborator
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
Role: lead
A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
Role: lead
A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL
Role: collaborator